Loss Per Share (Q1) (Tables)

3 Months Ended

12 Months Ended

Mar. 31, 2021

Dec. 31, 2020

Schedule of Earnings Per Share, Basic and Diluted

The following table sets forth the computation of the basic and diluted net loss per share attributable to the Class 1 and Class 2 common stockholders, which have the same rights and privileges except for voting rights, for the for the three months ended March 31, 2021 and 2020 (in thousands, except per share amounts):

	March 31,
	2021			2020
Numerator:
Net loss	$	(22,794	)	$	(7,097	)
Denominator:
Weighted-average common shares outstanding		144,207			99,804
Net loss per share attributable to common stockholders (Class 1 and Class 2), basic and diluted	$	(0.16	)	$	(0.07	)

The following table sets forth the computation of the basic and diluted net loss per share attributable to common stockholders for the years ended December 31, 2020, 2019 and 2018 (in thousands, except per share amounts), as retroactively adjusted (refer to Note 1):

	December 31,
	2020			2019			2018
Numerator:
Net loss	$	(17,027	)	$	(22,803	)	$	(18,231	)
Denominator:
Weighted-average common shares outstanding		100,022,546			99,272,157			97,951,673
Net loss per share attributable to common stockholders, basic and diluted	$	(0.17	)	$	(0.23	)	$	(0.19	)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

Since the Company was in a loss position for all periods presented, basic net loss per share is the same as diluted net loss per share for all periods as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be antidilutive, were as follows as of the dates presented, based on the underlying shares and not considering all factors that would be involved in determining the common stock equivalents:

	March 31,
	2021		2020
Options to purchase common stock		22,383,267		12,870,603
Restricted Stock Units (RSU’s)		834,228		—
Warrants		12,500,000		12,500,000
		35,717,495		25,370,603

Potentially dilutive securities, as retroactively adjusted (refer to Note 1), that were not included in the diluted per share calculations because they would be antidilutive, were as follows as of the dates presented, based on the underlying shares and not considering all factors that would be involved in determining the common stock equivalents:

	December 31,
	2020		2019		2018
Options to purchase common stock		16,170,737		11,653,411		12,591,770
Series C Warrants		105,005		105,005		105,005
		16,275,742		11,758,416		12,696,775